The slip
PARKINSON RECEIPTno. 3949
20 Oct 2026, 06:33 UTColigodendrocytes, braak
predictionJAM3 in oligodendrocytes tracks Braak Lewy-body stage
registerede61a9426a294a908
discovery+0.36 p=0.341 n=9
replication+0.11 p=0.775 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.36, p 0.341)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTb9570582a34d0bb1b1f691a6…
follows 18581908b7ad…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 3949: JAM3 in oligodendrocytes, braak
- power
- full sample +0.23 (p 0.365, n 18), 95% CI -0.27 to +0.63. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.25 (p 0.319, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.25 (p 0.319, n 18). could be the mix.
- skeptic
- leave-one-out range +0.12 to +0.39, sign flips 0; without severely affected donors +0.23 (p 0.365, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for JAM3 in oligodendrocytes.
case closed: nothing better to follow up.